Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

Articles published in
Am J Obstet Gynecol
    September 2023
  1. JONSSON S, Jonsson H, Lundin E, Haggstrom C, et al
    Pelvic inflammatory disease and risk of epithelial ovarian cancer. A national population-based case-control study in Sweden.
    Am J Obstet Gynecol. 2023 Sep 29:S0002-9378(23)00723.
    >> Share

  2. LEE SS, Dinicu A, Arthurs L, Shileds D, et al
    Demographic reporting and language exclusion in gynecologic oncology clinical trials.
    Am J Obstet Gynecol. 2023 Sep 24:S0002-9378(23)00639.
    >> Share

    August 2023
  3. ZHOU J, Wu P, Zhang Y
    Patient-reported quality of life might depend on prophylactic or therapeutic surgery for women with higher genetic predisposition to breast/ovarian cancer.
    Am J Obstet Gynecol. 2023 Aug 31:S0002-9378(23)00597.
    >> Share

  4. WEI X, Oxley S, Sideris M, Legood R, et al
    Patient-reported quality of life following prophylactic surgery for breast and ovarian cancer prevention: Response.
    Am J Obstet Gynecol. 2023 Aug 31:S0002-9378(23)00598.
    >> Share

    June 2023
  5. BLUSTEIN P, Werner SR, Uppalapati P, Leung TM, et al
    Adherence to Risk-Reducing Salpingo-Oophorectomy Guidelines Among Gynecologic Oncologists Compared to General Gynecologists.
    Am J Obstet Gynecol. 2023 Jun 10:S0002-9378(23)00380.
    >> Share

    April 2023
  6. GOMEZ SL, Mcguire V, Collin LJ, Dempsey L, et al
    Disparities in ovarian cancer survival: does place matter?
    Am J Obstet Gynecol. 2023 Apr 26:S0002-9378(23)00263.
    >> Share

  7. WEI X, Oxley S, Sideris M, Kalra A, et al
    Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis.
    Am J Obstet Gynecol. 2023 Apr 12:S0002-9378(23)00240.
    >> Share

  8. TERRA L, Beekman MJ, Engelhardt EG, Heemskerk-Gerritsen BAM, et al
    Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy.
    Am J Obstet Gynecol. 2023;228:440.
    >> Share

    March 2023
  9. MINALT N, Caldwell A, Yedlicka GM, Joseph S, et al
    Association of Intrauterine Device Use and Endometrial, Cervical, and Ovarian Cancer: an Expert Review.
    Am J Obstet Gynecol. 2023 Mar 29:S0002-9378(23)00224.
    >> Share

  10. FOSTER KI, Flores Legarreta A, Kamat R, Handley KF, et al
    Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors.
    Am J Obstet Gynecol. 2023 Mar 10:S0002-9378(23)00148.
    >> Share

    November 2022
  11. CATHCART AM, Nezhat FR, Emerson J, Pejovic T, et al
    Adnexal masses during pregnancy: diagnosis, treatment and prognosis.
    Am J Obstet Gynecol. 2022 Nov 18:S0002-9378(22)02179.
    >> Share

    August 2022
  12. BODURTHA SMITH AJ, Alvarez R, Heintz J, Haggerty A, et al
    Disparities in Biomarker Testing in Ovarian Cancer: A Real-World Analysis.
    Am J Obstet Gynecol. 2022 Aug 22. pii: S0002-9378(22)00686.
    >> Share

    June 2022
  13. MORUZZI MC, Bolomini G, Esposito R, Mascilini F, et al
    Diagnostic performance of ultrasound in assessing the extension of disease in advanced ovarian cancer.
    Am J Obstet Gynecol. 2022 Jun 22. pii: S0002-9378(22)00367.
    >> Share

    May 2022
  14. CHAMBERS LM, O'Malley DM, Coleman RL, Herzog TJ, et al
    Is there a "Low Risk" Patient Population in Advanced Epithelial Ovarian Cancer?: A Critical Analysis.
    Am J Obstet Gynecol. 2022 May 28. pii: S0002-9378(22)00412.
    >> Share

    April 2022
  15. HUEPENBECKER SP, Fu S, Sun CC, Zhao H, et al
    Medicaid expansion and 2-year survival in women with gynecologic cancer: a difference-in-difference analysis.
    Am J Obstet Gynecol. 2022 Apr 29. pii: S0002-9378(22)00326.
    >> Share

  16. ORLANDO MS, Cadish LA, Shepherd JP, Falcone T, et al
    Salpingo-Oophorectomy or Surveillance for Ovarian Endometrioma in Asymptomatic Premenopausal Women: a Cost-Effectiveness Analysis.
    Am J Obstet Gynecol. 2022 Apr 28. pii: S0002-9378(22)00324.
    >> Share

  17. KARIA PS, Huang Y, Tehranifar P, Visvanathan K, et al
    Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States.
    Am J Obstet Gynecol. 2022 Apr 27. pii: S0002-9378(22)00317.
    >> Share

  18. HUO N, Smith CY, Gazzuola Rocca L, Rocca WA, et al
    Risk of de novo cancer after premenopausal bilateral oophorectomy.
    Am J Obstet Gynecol. 2022;226:539.
    >> Share

    February 2022
  19. MAI PL, Miller A, Black A, Falk RT, et al
    Effect of Risk-Reducing Salpingo-Oophorectomy on Sex-Steroid Hormone Serum Levels among Post-Menopausal Women: An NRG Oncology/GOG Study.
    Am J Obstet Gynecol. 2022 Feb 22. pii: S0002-9378(22)00124.
    >> Share

    January 2022
  20. XHOLLI A, Kratochwila C, Ferrero S, Moioli M, et al
    Role of three-dimensional ultrasound in ovarian cancer staging.
    Am J Obstet Gynecol. 2022 Jan 6. pii: S0002-9378(22)00001.
    >> Share

    November 2021
  21. SMITH MJ, Gerber D, Olsen A, Khouri OR, et al
    Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations.
    Am J Obstet Gynecol. 2021;225:508.
    >> Share

  22. COREY L, Cote ML, Ruterbusch JJ, Winer I, et al
    Disparities in Adjuvant Treatment of High-Grade Endometrial Cancer in the Medicare Population.
    Am J Obstet Gynecol. 2021 Nov 1. pii: S0002-9378(21)01179.
    >> Share

    October 2021
  23. CHI-HAU C
    Decidualized ovarian endometrioma.
    Am J Obstet Gynecol. 2021 Oct 7. pii: S0002-9378(21)01104.
    >> Share

  24. MANDELBAUM RS, Matsuzaki S, Sangara RN, Klar M, et al
    Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
    Am J Obstet Gynecol. 2021;225:399.
    >> Share

    September 2021
  25. CUSIMANO MC, Ferguson SE, Moineddin R, Chiu M, et al
    Ovarian Cancer Incidence and Death in Average-Risk Women Undergoing Bilateral Salpingo-Oophorectomy at Benign Hysterectomy.
    Am J Obstet Gynecol. 2021 Sep 23. pii: S0002-9378(21)01048.
    >> Share

  26. VAN LIESHOUT LAM, Gelderblom ME, DE Hullu JA, The R, et al
    Primary prevention of ovarian cancer: a patient decision aid for opportunistic salpingectomy.
    Am J Obstet Gynecol. 2021 Sep 15. pii: S0002-9378(21)01007.
    >> Share

    June 2021
  27. MARCHAND G, Mills K, Ware K
    Reply to a question regarding ovarian cancer prevention with partial salpingectomy versus complete.
    Am J Obstet Gynecol. 2021 Jun 30. pii: S0002-9378(21)00769.
    >> Share

    May 2021
  28. MARCHOCKI Z, Cusimano MC, Clarfield L, Rachel Kim S, et al
    Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics.
    Am J Obstet Gynecol. 2021 May 28. pii: S0002-9378(21)00602.
    >> Share

  29. VAN WEELDEN WJ, Lalisang RI, Bulten J, Lindemann K, et al
    IMPACT OF HORMONAL BIOMARKERS ON RESPONSE TO HORMONAL THERAPY IN ADVANCED AND RECURRENT ENDOMETRIAL CANCER.
    Am J Obstet Gynecol. 2021 May 18. pii: S0002-9378(21)00554.
    >> Share

  30. SUH-BURGMANN E, Brasic N, Jha P, Hung YY, et al
    Ultrasound characteristics of early stage high-grade serous ovarian cancer.
    Am J Obstet Gynecol. 2021 May 13. pii: S0002-9378(21)00551.
    >> Share

    March 2021
  31. NAUMANN RW, Hughes BN, Brown J, Drury LK, et al
    The Impact of Opportunistic Salpingectomy on Ovarian Cancer Mortality and Healthcare Costs: A Call For Universal Insurance Coverage.
    Am J Obstet Gynecol. 2021 Mar 30. pii: S0002-9378(21)00212.
    >> Share

    February 2021
  32. HARRISON RF, Fu S, Sun CC, Zhao H, et al
    Patient cost-sharing during poly(ADP-ribose) polymerase inhibitor treatment in ovarian cancer.
    Am J Obstet Gynecol. 2021 Feb 4. pii: S0002-9378(21)00086.
    >> Share

    January 2021
  33. SCHRIJVER LH, Antoniou AC, Olsson H, Mooij TM, et al
    Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
    Am J Obstet Gynecol. 2021 Jan 22. pii: S0002-9378(21)00038.
    >> Share

  34. MATSUO K, Mandelbaum RS, Matsuzaki S, Klar M, et al
    Ovarian conservation for young women with early-stage low-grade endometrial cancer: A proposal for a two-step approach.
    Am J Obstet Gynecol. 2021 Jan 4. pii: S0002-9378(20)32630.
    >> Share

    December 2020
  35. MASCIULLO V, Trivellizzi N, Zannoni G, Catena U, et al
    Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
    Am J Obstet Gynecol. 2020 Dec 29. pii: S0002-9378(20)32627.
    >> Share

    August 2020
  36. SAMIMI G, Sathyamoorthy N, Tingen CM, Mazloomdoost D, et al
    Report of NCI and NICHD-Sponsored Workshop: Gynecology and Women's Health-Benign Conditions and Cancer.
    Am J Obstet Gynecol. 2020 Aug 21. pii: S0002-9378(20)30877.
    >> Share

  37. WESTIN SN, Fellman B, Sun CC, Broaddus RR, et al
    Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial Cancer.
    Am J Obstet Gynecol. 2020 Aug 14. pii: S0002-9378(20)30861.
    >> Share

  38. ALBRIGHT BB, Nasioudis D, Craig S, Moss HA, et al
    Impact of Medicaid expansion on women with gynecologic cancer: A difference-in-difference analysis.
    Am J Obstet Gynecol. 2020 Aug 7. pii: S0002-9378(20)30835.
    >> Share

    July 2020
  39. PADILLA-ISERTE P, Lago V, Tauste C, DIaz-Feijoo B, et al
    Impact of uterine manipulator on oncological outcome in endometrial cancer surgery.
    Am J Obstet Gynecol. 2020 Jul 18. pii: S0002-9378(20)30744.
    >> Share

  40. FERRARI F, Forte S, Sbalzer N, Zizioli V, et al
    Validation of an enhanced recovery after surgery protocol in gynecological surgery: an Italian randomized study.
    Am J Obstet Gynecol. 2020 Jul 8. pii: S0002-9378(20)30720.
    >> Share

    May 2020
  41. CHAMBERS LM, Morton M, Lampert E, Yao M, et al
    Use of Prophylactic Closed Incision Negative Pressure Therapy Is Associated with Reduced Surgical Site Infections in Gynecologic Oncology Patients Undergoing Laparotomy.
    Am J Obstet Gynecol. 2020 May 14. pii: S0002-9378(20)30536.
    >> Share

    April 2020
  42. MANDELBAUM RS, Adams CL, Yoshihara K, Nusbaum DJ, et al
    The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecological disease in the United States.
    Am J Obstet Gynecol. 2020 Apr 30. pii: S0002-9378(20)30514.
    >> Share

    March 2020
  43. MILLER H, Matsuo K
    A cesarean delivery sequela: Scar rupture and tumor spill during laparoscopic hysterectomy for endometrial cancer.
    Am J Obstet Gynecol. 2020 Mar 18. pii: S0002-9378(20)30337.
    >> Share

  44. KASPERS M, Llamocca E, Quick A, Dholakia J, et al
    Black and Hispanic women are less likely than White women to receive guideline-concordant endometrial cancer treatment.
    Am J Obstet Gynecol. 2020 Mar 3. pii: S0002-9378(20)30232.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016